Danaher (NYSE:DHR) EVP Gregory Milosevich Sells 2,100 Shares of Stock

Danaher Corporation (NYSE:DHR) EVP Gregory Milosevich sold 2,100 shares of the business’s stock in a transaction dated Monday, November 9th. The shares were sold at an average price of $230.62, for a total value of $484,302.00. Following the completion of the sale, the executive vice president owned 22,367 shares in the company, valued at $5,158,277.54. This represents a 8.58% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.

Danaher Price Performance

NYSE DHR opened at $236.41 on Wednesday. The company has a quick ratio of 1.29, a current ratio of 1.63 and a debt-to-equity ratio of 0.45. The company has a market cap of $166.32 billion, a PE ratio of 38.69, a price-to-earnings-growth ratio of 2.95 and a beta of 0.76. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80. The firm’s 50-day simple moving average is $221.10 and its two-hundred day simple moving average is $201.55.

Danaher (NYSE:DHR) last posted its earnings results on Wednesday, October 21st. The conglomerate reported $2.11 earnings per share for the quarter, topping the consensus estimate of $1.92 by $0.19. Danaher had a net margin of 16.91% and a return on equity of 11.17%. The firm had revenue of $6.55 billion during the quarter, compared to the consensus estimate of $6.56 billion. During the same quarter last year, the company earned $1.89 earnings per share. The company’s revenue was up 8.3% on a year-over-year basis. Research analysts predict that Danaher Corporation will post 8.59 earnings per share for the current year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, October 30th. Investors of record on Wednesday, September 30th were issued a $0.40 dividend. The ex-dividend date of this dividend was Wednesday, September 30th. This represents a $1.60 annualized dividend and a yield of 0.7%. Danaher’s dividend payout ratio (DPR) is 26.19%.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on DHR shares. Stifel Nicolaus lifted their price objective on shares of Danaher from $220.00 to $260.00 and gave the company a “buy” rating in a research note on Thursday, October 22nd. UBS Group restated a “buy” rating and set a $260.00 target price on shares of Danaher in a research report on Thursday, October 22nd. DZ Bank lowered Danaher from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 27th. JPMorgan Chase & Co. lifted their price target on Danaher from $250.00 to $270.00 and gave the company an “overweight” rating in a research report on Thursday, October 22nd. Finally, Barclays boosted their price objective on Danaher from $255.00 to $260.00 and gave the company an “overweight” rating in a research note on Thursday, October 22nd. Eighteen analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $242.91.

Institutional Trading of Danaher

Several institutional investors and hedge funds have recently modified their holdings of DHR. Main Street Group LTD bought a new stake in shares of Danaher during the 1st quarter valued at about $25,000. N.E.W. Advisory Services LLC purchased a new position in shares of Danaher during the second quarter worth about $25,000. Marquette Asset Management LLC increased its position in shares of Danaher by 192.1% in the third quarter. Marquette Asset Management LLC now owns 111 shares of the conglomerate’s stock worth $25,000 after purchasing an additional 73 shares during the last quarter. Field & Main Bank bought a new position in shares of Danaher in the second quarter worth approximately $29,000. Finally, Solstein Capital LLC bought a new position in shares of Danaher in the second quarter worth approximately $33,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

About Danaher

Danaher is a global science and technology company that develops and supplies products and services for biotechnology, life sciences, and diagnostics markets. Its offerings include instruments, reagents, consumables, software, and services used in research, drug development and manufacturing, and clinical testing. The company’s businesses include well-known brands such as Cytiva and Pall in bioprocessing and filtration, Beckman Coulter in laboratory and clinical diagnostics, Cepheid in molecular diagnostics, and Leica Microsystems in microscopy.